News and Announcements
iFAST Annual Update 2016; Launched FSMOne, Continued Efforts in China, Hong Kong and Malaysia
- Published January 31, 2017 10:53AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
iFAST Corporation Ltd.: Leading investment products distribution platform in Asia continues to strengthen investment and fintech capabilities in 2016
- Launched FSMOne (www.fsmone.com) in Dec 2016, giving investors community in Singapore the ability to invest seamlessly in multiple investment products including funds, robo-advisory portfolios, bonds, stocks, ETFs and insurance products, in one account
- Completed acquisition of a stockbroker in Hong Kong in Jan 2016 and launched insurance products on Fundsupermart Malaysia in July 2016
- Continuing efforts in China to build team of wealth advisers, as part of ‘platform-cum-IFA incubator’ strategy, and signing up additional Chinese companies to tap on the platform’s fintech investment capabilities
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
